Patience David 4

What Happened

• Patience David, Chief Financial Officer of TriSalus Life Sciences (TLSI), had 14,650 shares withheld on July 1, 2026 to satisfy tax withholding related to the vesting of previously granted restricted stock units (RSUs). The withholding was at $4.46 per share, resulting in a value of $65,339. This was a tax-withholding transaction (code F), not an open-market sale.

Key Details

• Transaction date: 2026-07-01
• Transaction type/code: Payment of tax liability (F) — shares withheld to cover RSU tax
• Shares withheld/disposed: 14,650
• Price used: $4.46 per share
• Total value withheld: $65,339
• Footnote: F1 — shares withheld by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with RSU vesting
• Filing date: Form filed 2026-07-06 for a 2026-07-01 transaction (appears later than the typical 2-business-day Form 4 filing window)
• Shares owned after transaction: Not specified in the provided filing excerpt

Context

• This was a routine, company-withheld tax payment upon RSU vesting (a cashless withholding), not an open-market sale. Such transactions generally reflect tax mechanics rather than a change in trading intent or view of the company.